Specialty Pharma Journal

FDA Approves Gavreto for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX:…
Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in NEJM

WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq: INCY) today announced that data from th…
Natera Announces SMART Study Data for Aneuploidy and 22q Unblinded

SAN CARLOS, Calif., Sept. 2, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and le…
Aimmune Agrees to be Acquired by Nestlé Health Science for $2 Billion

BRISBANE, Calif.–(BUSINESS WIRE)–Aug. 31, 2020– Aimmune Therapeutics Inc. (Nasdaq:…
Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (Nasdaq: TWST) …

The 2017 Hepatitis C Treatment Landscape

February 22, 2017 Blog

Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
Understanding the Hepatitis C Testing Process

February 15, 2017 Blog
Potential New Medication for Lymphoma

February 8, 2017 Blog

Guardant Health Receives FDA Emergency Use Authorization for its Guardant-19 Next Generation Sequencing-Based COVID-19 Test

August 26, 2020 FDA News, Infectious Diseases, Technology & Devices

REDWOOD CITY, Calif., Aug. 24, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) announces that …

Phase 3 Trial of Onconova’s IV Rigosertib Fails to Meet Primary Endpoint in Patients with Higher-Risk Myelodysplastic Syndromes

August 26, 2020 Oncology

NEWTOWN, Pa., Aug. 24, 2020 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX) a biopharmaceutical …

Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement

August 26, 2020 Business News

BOSTON, Aug. 24, 2020 /PRNewswire/ — Yumanity Therapeutics and Proteostasis Therapeutics, Inc. (Nasdaq: PTI) today …

Novartis Announces Phase 3 Study of Sparalizumab in Combination with Tafinlar + Mekinist Fails to Meet its Primary Endpoint in Advanced Melanoma

August 26, 2020 Oncology

Basel, August 22, 2020 — Novartis announced today that the Phase III COMBI-i study evaluating the …

Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19

August 21, 2020 Infectious Diseases, Vaccines & Immunizations

NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today shared additional Phase …

FDA Approves Kyprolis in Combination with Darzalex and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

August 21, 2020 FDA News, Oncology

THOUSAND OAKS, Calif., Aug. 20, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved …

AstraZeneca and RenalytixAI to Collaborate to Develop Precision Medicine Strategies to Improve Outcomes for Patients with Chronic Disease

August 21, 2020 Business News, Precision Medicine

NEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), today announced …

FDA Approves Novartis’ Kesimpta, the First and Only Self-Administered, Targeted B-Cell Therapy for Patients with Relapsing Multiple Sclerosis

August 21, 2020 FDA News, Multiple Sclerosis

Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) …

Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting with Treatments for COVID-19 and Cancer

August 21, 2020 Business News, Infectious Diseases, Oncology

SAN DIEGO AND BOSTON, Aug. 20, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, …

FDA Grants Fast Track Designation to Kazia’s Paxalisib for Treatment of Glioblastoma

August 21, 2020 FDA News, Oncology

SYDNEY, Aug. 20, 2020 /PRNewswire/ — Kazia Therapeutics Limited (ASX: KZA;NASDAQ: KZIA), an Australian oncology-focused …

AbCellera Acquires OrthoMab Bispecific Platform to Propel the Development of Antibody Therapies for Pharma and Biotech Partners

August 21, 2020 Business News, Technology & Devices

VANCOUVER, British Columbia–(BUSINESS WIRE)–AbCellera today announced the acquisition of the OrthoMab bispecific platform from Dualogics, LLC. …

CENTOGENE and Evotec Expand Collaboration into Gaucher Disease

August 21, 2020 Business News, Rare Diseases

CAMBRIDGE, Mass. and ROSTOCK, Germany and HAMBURG, Germany and BERLIN, Aug. 20, 2020 (GLOBE NEWSWIRE) …

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX-200 for the Treatment of Patients with Juvenile Neuronal Ceroid Lipofuscinosis

August 20, 2020 FDA News, Lysosomal Storage Disorders, Rare Diseases

PARAMUS, N.J., Aug. 20, 2020 /PRNewswire/ — Polaryx Therapeutics Inc., a biotech company developing small …

Puma Biotechnology Announces Publication of Interim Results of Phase II Neratinib Trial in Patients with HER2+ Breast Cancer

August 20, 2020 Oncology

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the publication of interim …

New England Journal of Medicine Publishes Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol

August 20, 2020 Lysosomal Storage Disorders, Specialty Pharmacy

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine (NEJM) published positive results from the Phase …

Page 4 of 325« First...2 345 6 »10 20 30...Last »

Recent Posts